Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer-Reference-Cited by-同舟云学术

Systemic therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer

Published:2022-01-10 Issue:1 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Roberts Kate E¹²,Adsett India T³,Rickett Kirsty⁴,Conroy Sophie M⁵,Chatfield Mark D⁶,Woodward Natasha E²⁷

Affiliation:

1. Department of Medical Oncology; Princess Alexandra Hospital; Woolloongabba Australia

2. School of Clinical Medicine, Mater Clinical Unit; Mater Hospital, University of Queensland; South Brisbane Australia

3. Ipswich Hospital, Queensland Health; Ipswich Australia

4. The University of Queensland Library; UQ/Mater McAuley Library; Brisbane Australia

5. Medical Oncology; Mater Health; Brisbane Australia

6. Centre for Health Services Research; The University of Queensland; Woolloongabba Australia

7. Department of Medical Oncology; Mater Misericordiae Ltd; South Brisbane Australia

Publisher

Wiley

Subject

Pharmacology (medical)

Reference203 articles.

1. Testosterone undecanoate treatment reduces joint morbidities induced by anastrozole therapy in postmenopausal women with breast cancer: results of a double-blind, randomized phase II trial;Birrell;Cancer Research,2009

2. Birrell SN Reduction of side effects from aromatase inhibitors used for treating breast cancer United States Patent Application Publication US 2012/0122824 A1

3. Androgen therapy for breast cancer patients with aromatase inhibitor induced side effects clinicaltrials.gov/show/NCT00497458

4. A randomized, double-blind, placebo controlled trial of testosterone for treatment of postmenopausal women with aromatase inhibitor-induced arthralgias: Alliance study A221102;Cathcart-Rake;Supportive Care in Cancer,2020

5. A randomized, double-blind, placebo-controlled trial of testosterone (T) for aromatase inhibitor-induced arthralgias (AIA) in postmenopausal women: Alliance A221102;Leon-Ferre;Cancer Research,2019

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rheumatoid Arthritis-Like Symptoms After Taking Relugolix, With Primary Exacerbation After Discontinuation of the Drug;Cureus;2024-02-04

2. Clinical guidelines for managing menopausal symptoms in women with (a history of) breast cancer;Facts, Views and Vision in ObGyn;2023-11-14

3. 10 years or less of extended adjuvant endocrine therapy for postmenopausal breast cancer patients: A systematic review and network meta-analysis;European Journal of Cancer;2023-11

4. Knowledge Graph of Breast Cancer Prevention and Treatment: based on Literature Data (Preprint);JMIR Medical Informatics;2023-08-26

5. Knowledge graph of breast cancer prevention and treatment - based on artificial intelligence theory (Preprint);2023-08-26